Gene · 1830
Papers2,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Need of Differential Diagnosis Between Vulvar Lichen Sclerosus and Autoimmune Dermatoses in Adolescent Girls. | Dermatol Ther (Heidelb) | 2024 | 38451422 | PubTator, text mining | PubMed |
| Rituximab in the Management of Autoimmune Bullous Diseases: A Treatment-Resistant Case Series from a Single Central European Referral Center. | Medicina (Kaunas) | 2024 | 38399557 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Immunobiological Effects and Prognostic Significance Related to Endoplasmic Reticulum Stress in Pancreatic Carcinoma. | Altern Ther Health Med | 2024 | 38330578 | PubTator, text mining | PubMed |
| Aspirin-exacerbated respiratory disease is associated with variants in filaggrin, epithelial integrity, and cellular interactions. | J Allergy Clin Immunol Glob | 2024 | 38317805 | PubTator, text mining | PubMed |
| Bullous pemphigoid with prominent mucosal involvement in the setting of renal allograft rejection. | JAAD Case Rep | 2024 | 38292570 | PubTator, text mining | PubMed |
| Oral Lichen Planus: An Updated Review of Etiopathogenesis, Clinical Presentation, and Management. | Indian Dermatol Online J | 2024 | 38283029 | PubTator, text mining | PubMed |
| Adalimumab induced exacerbation of psoriasis in patients with combined pemphigus: A case report. | Medicine (Baltimore) | 2024 | 38277534 | PubTator, text mining | PubMed |
| Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study. | Acta Derm Venereol | 2024 | 38270257 | PubTator, text mining | PubMed |
| Proteomic insights into mental health status: plasma markers in young adults. | Transl Psychiatry | 2024 | 38267423 | PubTator, text mining | PubMed |
| Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial. | JAMA Dermatol | 2024 | 38265821 | PubTator, text mining | PubMed |
| A complex of cadherin 17 with desmocollin 1 and p120-catenin regulates colorectal cancer migration and invasion according to the cell phenotype. | J Exp Clin Cancer Res | 2024 | 38263178 | PubTator, text mining | PubMed |
| Gingival Manifestations in Oral Chronic Autoimmune Bullous Diseases: A Retrospective Study. | Medicina (Kaunas) | 2024 | 38256427 | PubTator, text mining | PubMed |
| Is It Time to Reconsider Rituximab Dosing Regimens for Pemphigus Vulgaris? | Antibodies (Basel) | 2024 | 38247568 | PubTator, text mining | PubMed |
| JNK inhibition enhances cell-cell adhesion impaired by desmoglein 3 gene disruption in keratinocytes. | Histochem Cell Biol | 2024 | 38227055 | PubTator, text mining | PubMed |
| Novel nanoparticle AuNCs conjugated with Desmoglein-3 antibody for FL/CT dual-mode targeted imaging and precise treatment of lung squamous cell carcinoma. | J Colloid Interface Sci | 2024 | 38224630 | PubTator, text mining | PubMed |
| A case of anti-laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration. | J Dermatol | 2024 | 38214494 | PubTator, text mining | PubMed |
| Pemphigus vulgaris relapsed with serological shift from single-positive desmoglein-3 antibodies to single-positive desmoglein-1 antibodies. | J Dermatol | 2024 | 38212901 | PubTator, text mining | PubMed |
| Comparison of gut microbiota dysbiosis between pemphigus vulgaris and bullous pemphigoid. | Int Immunopharmacol | 2024 | 38185033 | PubTator, text mining | PubMed |
| EPYC functions as a novel prognostic biomarker for pancreatic cancer. | Sci Rep | 2024 | 38184732 | PubTator, text mining | PubMed |
| Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironment. | BMC Urol | 2024 | 38172792 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1830/papers?page=9